Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Inflammatory Bowel Disease Treatment Market: By Drug: Aminosalicylates, Antibiotics, Corticosteroids, Immunomodulators, Biologics, Others; By Disease: Ulcerative Colitis, Others; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Inflammatory Bowel Disease Treatment Market Outlook

The global inflammatory bowel disease treatment market attained a value of about USD 16.7 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 4.5% to reach a value of nearly USD 22 billion by 2026.

 

Global Inflammatory Bowel Disease Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Biosimilars are among the key drivers controlling the market growth as a whole. Biosimilars are anticipated to be less expensive than biotechnological products, which in developing countries make them more accessible. One of the determinants accountable for launching new biologics is the anticipated patent expiry of some of the drugs.

 

Properties and Applications

Inflammatory bowel disease (IBD) is a term used to refer to two diseases (Crohn's disease and ulcerative colitis) characterized by persistent gastrointestinal inflammation (GI) tract. Inflammation for a long period contributes to the damage of the GI tract.

 

Global Inflammatory Bowel Disease Treatment Market By Drug

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on the drug, the inflammatory bowel disease market can be divided into:

  • Aminosalicylates
  • Antibiotics
  • Corticosteroids
  • Immunomodulators
  • Biologics
  • Others

Based on disease, the market is divided into:

  • Ulcerative Colitis
  • Crohn's Disease
  • Indeterminate Colitis

The market can be broadly categorised based on its end-use segments into:

  • Fertility Centres 
  • Hospitals and Surgical Clinics 
  • Research Institutes 
  • Cryobanks

The EMR report looks into the regional markets of inflammatory bowel disease treatment like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Inflammatory Bowel Disease Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global industry for inflammatory bowel disease treatment is growing globally owing to factors like the rising prevalence of Crohn's disease and ulcerative colitis, increasing government support for research into inflammatory bowel diseases, and the advancements in medical technology. In addition, an increasing number of drugs in clinical trial and the growing popularity of pre-biotic and pro-biotic food products are likely to contribute to the market growth during the evaluation period.

The rise of the market for inflammatory bowel disorders is, however, expected to be limited by the higher costs of capital needed for drug discovery, the inadequate clinical efficacy of therapy, and stringent drug regulatory policies.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global inflammatory bowel disease treatment industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Abbott Laboratories (NYSE: ABT)
  • Biocon Ltd. 
  • F. Hoffmann-La Roche Ag 
  • Johnson & Johnson 
  • Mylan Pharmaceuticals Ltd. 
  • Novartis Ag 
  • Pfizer Inc. 
  • Quest Medical, Inc.
  • Sanofi S.A. 
  • Takeda Pharmaceutical Company Ltd. 

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug, Disease, End Use, Region
Breakup by Drug Aminosalicylates, Antibiotics, Corticosteroids, Immunomodulators, Biologics, Others
Breakup by Disease Ulcerative Colitis, Crohn’s Disease, Indeterminate Colitis
Breakup by End Use Fertility Centres, Hospitals and Surgical Clinics, Research Institutes, Cryobanks
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Abbott Laboratories [ABT (NYSE)], Biocon Ltd. [BIOCON (NSE)], F. Hoffmann-La Roche Ag
[ROG (SWX)], Johnson & Johnson [ROG (SWX)], Mylan Pharmaceuticals Ltd.
[MYL (NASDAQ)], Novartis Ag [ NOVN (SWX)], Pfizer Inc. [PFE (NYSE)],
Quest Medical, Inc., Sanofi S.A. [SAN (EPA)], Takeda Pharmaceutical Company Ltd. [4502 (TYO)]
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Inflammatory Bowel Disease Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Inflammatory Bowel Disease Treatment Historical Market (2017-2021) 
    8.3    Global Inflammatory Bowel Disease Treatment Market Forecast (2022-2027)
    8.4    Global Inflammatory Bowel Disease Treatment Market by Drug
        8.4.1    Aminosalicylates
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Antibiotics
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Corticosteroids
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Immunomodulators
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
        8.4.5    Biologics
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2017-2021)
            8.4.5.3    Forecast Trend (2022-2027)
        8.4.6    Others
    8.5    Global Inflammatory Bowel Disease Treatment Market by Disease
        8.5.1    Ulcerative Colitis
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Crohn’s Disease
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Indeterminate Colitis
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
    8.6    Global Inflammatory Bowel Disease Treatment Market by End Use
        8.6.1    Fertility Centers
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Hospitals and Surgical Clinics
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Research Institutes
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Cryobanks
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021)
            8.6.4.3    Forecast Trend (2022-2027)
    8.7    Global Inflammatory Bowel Disease Treatment Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
    9.2.1    Historical Trend (2017-2021)
    9.2.2    Forecast Trend (2022-2027)
    9.2.3    Breakup by Country 
        9.2.3.1    United Kingdom
        9.2.3.2    Germany
        9.2.3.3    France
        9.2.3.4    Italy
        9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Abbott Laboratories
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Biocon, Ltd.
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    F. Hoffmann-La Roche Ag
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Novartis Ag
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Pfizer Inc.
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Johnson & Johnson
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7    Mylan Pharmaceuticals Ltd.
            11.2.7.1    Company Overview
            11.2.7.2    Product Portfolio
            11.2.7.3    Demographic Reach and Achievements
            11.2.7.4    Certifications
        11.2.8    Quest Medical, Inc.
            11.2.8.1    Company Overview
            11.2.8.2    Product Portfolio
            11.2.8.3    Demographic Reach and Achievements
            11.2.8.4    Certifications
        11.2.9    Sanofi S.A.
            11.2.9.1    Company Overview
            11.2.9.2    Product Portfolio
            11.2.9.3    Demographic Reach and Achievements
            11.2.9.4    Certifications
        11.2.10    Takeda Pharmaceutical Company Ltd.
            11.2.10.1    Company Overview
            11.2.10.2    Product Portfolio
            11.2.10.3    Demographic Reach and Achievements
            11.2.10.4    Certifications
        11.2.11    Others
12    Industry Events and Developments


List of Key Figures and Tables

1.    Global Inflammatory Bowel Disease Treatment Market: Key Industry Highlights, 2017 and 2027
2.    Global Inflammatory Bowel Disease Treatment Historical Market: Breakup by Drug (USD Million), 2017-2021
3.    Global Inflammatory Bowel Disease Treatment Market Forecast: Breakup by Drug (USD Million), 2022-2027
4.    Global Inflammatory Bowel Disease Treatment Historical Market: Breakup by Disease (USD Million), 2017-2021
5.    Global Inflammatory Bowel Disease Treatment Market Forecast: Breakup by Disease (USD Million), 2022-2027
6.    Global Inflammatory Bowel Disease Treatment Historical Market: Breakup by End Use (USD Million), 2017-2021
7.    Global Inflammatory Bowel Disease Treatment Market Forecast: Breakup by End Use (USD Million), 2022-2027
8.    Global Inflammatory Bowel Disease Treatment Historical Market: Breakup by Region (USD Million), 2017-2021
9.    Global Inflammatory Bowel Disease Treatment Market Forecast: Breakup by Region (USD Million), 2022-2027
10.    North America Inflammatory Bowel Disease Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
11.    North America Inflammatory Bowel Disease Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Europe Inflammatory Bowel Disease Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Europe Inflammatory Bowel Disease Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Asia Pacific Inflammatory Bowel Disease Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Asia Pacific Inflammatory Bowel Disease Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Latin America Inflammatory Bowel Disease Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Latin America Inflammatory Bowel Disease Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Middle East and Africa Inflammatory Bowel Disease Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Middle East and Africa Inflammatory Bowel Disease Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Global Inflammatory Bowel Disease Treatment Market Structure

Key Questions Answered in the Report

In 2020, the global inflammatory bowel disease treatment market attained a value of nearly USD 16.7 billion.

The market is projected to grow at a CAGR of 4.5% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach USD 22 billion by 2026.

Major industry drivers include the growing population, rising prevalence of Crohn's disease and ulcerative colitis, increasing government support for research into inflammatory bowel diseases, and the advancements in medical technology.

Key industry trends driving market growth are the growing popularity of pre-biotic and pro-biotic food products and biosimilars, which are anticipated to be less expensive than biotechnological products.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The significant drugs in this industry are amino salicylates, antibiotics, corticosteroids, immunomodulators and biologics, among others.

The major diseases targeted by this market include ulcerative colitis, Crohn's disease and indeterminate colitis.

The leading end use sectors are fertility centres, hospitals and surgical clinics, research institutes, and cryobanks.

The major players in the industry are Abbott Laboratories, Biocon Ltd., F. Hoffmann-La Roche Ag, Johnson & Johnson, Mylan Pharmaceuticals Ltd., Novartis Ag, Pfizer Inc., Quest Medical, Inc., Sanofi S.A., and Takeda Pharmaceutical Company Ltd.

Analyst Review

The global inflammatory bowel disease treatment market attained a value of USD 16.7 billion in 2020, driven by the rising prevalence of Crohn's disease. Aided by the growing popularity of pre-biotic and pro-biotic food products and biosimilars, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 4.5%. The market is projected to reach USD 22 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The drugs in this industry include amino salicylates, antibiotics, corticosteroids, immunomodulators and biologics, among others. The major diseases targeted by this market include ulcerative colitis, Crohn's disease, and indeterminate colitis. The leading end use sectors are fertility centres, hospitals and surgical clinics, research institutes and cryobanks. The major regional markets for inflammatory bowel disease treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abbott Laboratories, Biocon Ltd., F. Hoffmann-La Roche Ag, Johnson & Johnson, Mylan Pharmaceuticals Ltd., Novartis Ag, Pfizer Inc., Quest Medical, Inc., Sanofi S.A., and Takeda Pharmaceutical Company Ltd.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER